Buprenorphine 2 mg/1

Buprenorphine, the active ingredient in Buprenorphine, is a partial opioid agonist presented as a 2 mg/tablet for sublingual use. It is used to treat moderate to severe chronic pain and opioid dependence. GNH USA supplies Buprenorphine as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals and clinics worldwide.

Buprenorphine is a well-established medication for managing opioid use disorder and chronic pain. Its unique pharmacological profile makes it a valuable tool in addiction treatment and pain management.

Buprenorphine is used to manage opioid use disorder and moderate to severe chronic pain. It helps by:

- Opioid dependence treatment: Reduces withdrawal symptoms and cravings for opioids. - Chronic pain management: Provides analgesia for moderate to severe pain. - Opioid overdose prevention: Lowers the risk of overdose due to its ceiling effect on respiratory depression. - Maintenance therapy: Supports long-term recovery from opioid addiction. - Harm reduction: Helps individuals stabilize and reduce the harmful effects of opioid use.

Buprenorphine can cause various side effects, ranging from common to serious. Common Side Effects: - Nausea and vomiting - Constipation - Headache - Sweating - Dizziness - Insomnia - Fatigue

Serious or Rare Side Effects: - Respiratory depression - Allergic reactions - Liver toxicity - Hormonal imbalances - Dependence and abuse potential - Withdrawal symptoms upon discontinuation

Buprenorphine should be used with caution and under medical supervision. Important precautions include: - Pregnancy: Use with caution, as it may affect the newborn. - Breastfeeding: Consult a healthcare provider before use. - Driving: Avoid operating heavy machinery until the effects are known. - Alcohol: Avoid alcohol consumption to prevent increased sedation. - Other medications: Inform your doctor about all medications you are taking. - Storage: Store at room temperature between 20 and 25 degrees C (68 and 77 degrees F).

Buprenorphine can interact with other medications, potentially altering its effects or increasing the risk of side effects. Major Interactions (Avoid): - Other opioids: Can increase the risk of respiratory depression. - Benzodiazepines: Can cause severe sedation and respiratory depression. - Alcohol: Can enhance the sedative effects of buprenorphine. - MAO inhibitors: Can increase the risk of serotonin syndrome.

Moderate Interactions (Monitor Closely): - Antidepressants: May increase the risk of side effects. - Antipsychotics: Can enhance the sedative effects of buprenorphine. - Antihistamines: May increase drowsiness.